Status:
UNKNOWN
Study on the Protective Effect of Gastrodin on Myocardial Injury in Patients Undergoing Cardiac Surgery
Lead Sponsor:
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Conditions:
Cardiac Surgical Procedures
Eligibility:
All Genders
18+ years
Brief Summary
This study intends to include hypertrophic cardiomyopathy patients over 18 years old who underwent cardiac surgery in our hospital. Patients were divided into medication group and control group accord...
Eligibility Criteria
Inclusion
- Patients with hypertrophic cardiomyopathy aged≥18 years, regardless of gender;
- Patients undergoing elective hypertrophic cardiomyopathy outflow tract surgery;
- Signed informed consent, good compliance.
Exclusion
- suffering from more serious genetic diseases (such as immunodeficiency, thalassemia, etc.);
- moderate to severe malnutrition, moderate to severe anemia;
- persistent infection;
- severe preoperative underlying diseases (such as severe liver and kidney dysfunction)
Key Trial Info
Start Date :
August 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2023
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT06012968
Start Date
August 1 2023
End Date
October 1 2023
Last Update
August 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China, 430022